News
Heart murmurs occurring in nearly one in four adults, but recordings of stethoscope sounds have limited sensitivity in ...
The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...
The Department of Health and Human Services plans to cancel contracts and pull funding for some vaccines being developed to ...
While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...
The announcement, made by Health Secretary Robert F. Kennedy Jr., marks his latest effort to weave vaccine scepticism into ...
Out-licensing drugs to multinational corporations is a natural step for Chinese biotechs, but the recent rise in deals is ...
The United States Department of Health and Human Services said yesterday it would wind down mRNA vaccine development activities under its biomedical research unit.
Key Points Non-GAAP EPS was ($0.13), missing the consensus estimate by $0.02 (non-GAAP), due to higher pre-commercialization spending. Research and development expenses fell 48.2% compared to Q2 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results